HealthEquity Operating Margin 2014-2025 | HQY
Current and historical operating margin for HealthEquity (HQY) over the last 10 years. The current operating profit margin for HealthEquity as of April 30, 2025 is 18.87%.
| HealthEquity Operating Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Operating Income | Operating Margin |
| 2025-04-30 | $1.24B | $0.20B | 16.41% |
| 2025-01-31 | $1.20B | $0.16B | 13.58% |
| 2024-10-31 | $1.15B | $0.16B | 13.91% |
| 2024-07-31 | $1.10B | $0.17B | 15.56% |
| 2024-04-30 | $1.04B | $0.14B | 13.14% |
| 2024-01-31 | $1.00B | $0.12B | 11.81% |
| 2023-10-31 | $0.97B | $0.09B | 9.47% |
| 2023-07-31 | $0.94B | $0.07B | 7.14% |
| 2023-04-30 | $0.90B | $0.04B | 4.44% |
| 2023-01-31 | $0.86B | $0.01B | 1.16% |
| 2022-10-31 | $0.83B | $-0.03B | -3.61% |
| 2022-07-31 | $0.80B | $-0.04B | -4.53% |
| 2022-04-30 | $0.78B | $-0.04B | -4.50% |
| 2022-01-31 | $0.76B | $-0.02B | -3.17% |
| 2021-10-31 | $0.74B | $0.00B | 0.13% |
| 2021-07-31 | $0.74B | $0.01B | 1.76% |
| 2021-04-30 | $0.73B | $0.02B | 3.16% |
| 2021-01-31 | $0.73B | $0.03B | 4.64% |
| 2020-10-31 | $0.75B | $0.05B | 6.84% |
| 2020-07-31 | $0.72B | $0.05B | 6.77% |
| 2020-04-30 | $0.64B | $0.07B | 10.24% |
| 2020-01-31 | $0.53B | $0.08B | 14.66% |
| 2019-10-31 | $0.41B | $0.08B | 19.66% |
| 2019-07-31 | $0.32B | $0.09B | 27.81% |
| 2019-04-30 | $0.30B | $0.09B | 28.29% |
| 2019-01-31 | $0.29B | $0.08B | 27.53% |
| 2018-10-31 | $0.27B | $0.07B | 25.83% |
| 2018-07-31 | $0.26B | $0.07B | 25.19% |
| 2018-04-30 | $0.24B | $0.06B | 24.18% |
| 2018-01-31 | $0.23B | $0.05B | 23.58% |
| 2017-10-31 | $0.22B | $0.05B | 24.07% |
| 2017-07-31 | $0.20B | $0.05B | 23.27% |
| 2017-04-30 | $0.19B | $0.04B | 23.28% |
| 2017-01-31 | $0.18B | $0.04B | 23.03% |
| 2016-10-31 | $0.17B | $0.04B | 23.35% |
| 2016-07-31 | $0.16B | $0.04B | 23.23% |
| 2016-04-30 | $0.14B | $0.03B | 21.28% |
| 2016-01-31 | $0.13B | $0.03B | 19.69% |
| 2015-10-31 | $0.12B | $0.02B | 19.83% |
| 2015-07-31 | $0.11B | $0.02B | 19.63% |
| 2015-04-30 | $0.10B | $0.02B | 19.39% |
| 2015-01-31 | $0.09B | $0.02B | 18.18% |
| 2014-07-31 | $0.06B | $0.01B | 23.21% |
| 2014-04-30 | $0.05B | $0.01B | 24.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $7.725B | $1.200B |
| HealthEquity provides integrated solutions for health-care account management, health reimbursement arrangement and flexible spending accounts for health plans, insurance companies and third-party administrators in the United States. HealthEquity's flagship health savings account or HSA is a financial account through which consumers spend and save for the long term for healthcare on a tax-advantaged basis. This has provided the company with a competitive edge in the MedTech industry. Other than HSAs, the company offers Healthcare saving and spending platform, Investment platform and advisory services and Reimbursement arrangements. In addition, HealthEquity offers health reimbursement and flexible spending arrangements solutions; Employee Retirement Income Security Act's plan administration and investment services. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $147.378B | 27.33 |
| CVS Health (CVS) | United States | $92.778B | 11.54 |
| Elevance Health (ELV) | United States | $71.753B | 9.65 |
| Cencora (COR) | United States | $56.537B | 18.83 |
| DiDi Global (DIDIY) | China | $27.533B | 22.50 |
| Labcorp Holdings (LH) | United States | $23.101B | 18.36 |
| Natera (NTRA) | United States | $23.092B | 0.00 |
| BioMerieux (BMXMF) | France | $16.600B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $14.580B | 0.00 |
| ICON (ICLR) | Ireland | $14.370B | 13.83 |
| Medpace Holdings (MEDP) | United States | $13.359B | 35.35 |
| CochLear (CHEOY) | Australia | $12.878B | 0.00 |
| Solventum (SOLV) | United States | $12.673B | 13.08 |
| Viatris (VTRS) | United States | $12.300B | 4.38 |
| Caris Life Sciences,�Inc (CAI) | United States | $10.796B | 0.00 |
| Revvity (RVTY) | United States | $10.459B | 18.43 |
| Avantor (AVTR) | United States | $9.183B | 13.47 |
| Charles River Laboratories (CRL) | United States | $8.037B | 15.25 |
| Sonic Healthcare (SKHHY) | Australia | $7.750B | 0.00 |
| Bausch + Lomb (BLCO) | Canada | $5.179B | 34.83 |
| Sotera Health (SHC) | United States | $4.650B | 25.98 |
| BrightSpring Health Services (BTSG) | United States | $4.197B | 32.01 |
| Amplifon S.p.A (AMFPF) | Italy | $3.937B | 21.82 |
| GeneDx Holdings (WGS) | United States | $3.720B | 85.19 |
| Alignment Healthcare (ALHC) | United States | $3.240B | 0.00 |
| Concentras Parent (CON) | United States | $3.050B | 19.35 |
| Surgery Partners (SGRY) | United States | $2.909B | 36.60 |
| Organon (OGN) | United States | $2.449B | 2.67 |
| Premier (PINC) | United States | $2.138B | 19.77 |
| KindlyMD (NAKA) | United States | $2.046B | 0.00 |
| Progyny (PGNY) | United States | $2.035B | 43.04 |
| Ardent Health (ARDT) | United States | $1.816B | 7.01 |
| PACS (PACS) | United States | $1.774B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.511B | 25.59 |
| Pediatrix Medical (MD) | United States | $1.499B | 10.01 |
| Teladoc Health (TDOC) | United States | $1.366B | 0.00 |
| Omada Health (OMDA) | $1.364B | 0.00 | |
| Establishment Labs Holdings (ESTA) | $1.196B | 0.00 | |
| Ryman Healthcare (RYHTY) | New Zealand | $0.962B | 0.00 |
| Embecta (EMBC) | United States | $0.847B | 4.96 |
| AMN Healthcare Services Inc (AMN) | United States | $0.796B | 9.85 |
| CareDx (CDNA) | United States | $0.727B | 13.39 |
| Performant Healthcare (PHLT) | United States | $0.603B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.583B | 100.00 |
| Agilon Health (AGL) | United States | $0.530B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.517B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.488B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.466B | 6.99 |
| Nutex Health (NUTX) | United States | $0.465B | 7.05 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.424B | 0.00 |
| SBC Medicals (SBC) | United States | $0.424B | 9.27 |
| Enhabit (EHAB) | United States | $0.399B | 26.27 |
| So-Young (SY) | China | $0.390B | 0.00 |
| Oncology Institute (TOI) | United States | $0.318B | 0.00 |
| LifeMD (LFMD) | United States | $0.294B | 0.00 |
| Beauty Health (SKIN) | United States | $0.264B | 0.00 |
| Shoulder Innovations (SI) | United States | $0.226B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.173B | 0.00 |
| DocGo (DCGO) | United States | $0.153B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.122B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.066B | 0.00 |
| Biodesix (BDSX) | United States | $0.063B | 0.00 |
| NeueHealth (NEUE) | United States | $0.059B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.038B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.038B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.026B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.017B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.015B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.013B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.010B | 0.00 | |
| XWELL (XWEL) | United States | $0.006B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.005B | 0.00 |
| INVO Fertility (IVF) | United States | $0.004B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |